What is the address of DR. LIES CORNELISSEN?

The registered office of DR. LIES CORNELISSEN is located at Burgemeester J. Van Aperenstraat 44, 2320 Hoogstraten.

Is DR. LIES CORNELISSEN still active?

Yes. According to the CBE (16 September 2026) DR. LIES CORNELISSEN is active, legal situation “Normale toestand”, started on 14 July 2015.

Is DR. LIES CORNELISSEN registered on Peppol?

Yes, DR. LIES CORNELISSEN is registered on the Peppol network with ID 0208:0633825714.

What is the enterprise number of DR. LIES CORNELISSEN?

The enterprise number of DR. LIES CORNELISSEN is BE0633825714.

When was DR. LIES CORNELISSEN founded?

DR. LIES CORNELISSEN was founded on 14 July 2015.

Who are the directors of DR. LIES CORNELISSEN?

According to the 2025 annual accounts, the directors of DR. LIES CORNELISSEN are: LIES CORNELISSEN.

Is DR. LIES CORNELISSEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 14 July 2015; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. LIES CORNELISSEN make in 2025?

DR. LIES CORNELISSEN posted a profit after taxes of € 111,787 in financial year 2025.

What is the revenue of DR. LIES CORNELISSEN?

As a small company, DR. LIES CORNELISSEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 159,338.

Does DR. LIES CORNELISSEN have a website?

Yes, DR. LIES CORNELISSEN has a website at huisartsenhuis44.be.

DR. LIES CORNELISSEN (Private Limited) - Hoogstraten

Dossier DR. LIES CORNELISSEN, printed on 16 September 2026 from databakkes.be/en/0633825714/dr-lies-cornelissen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 61 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

DR. LIES CORNELISSEN from Hoogstraten, company number BE0633825714, closed financial year 2025 with a result of € 111,787 after tax. For that financial year DR. LIES CORNELISSEN recorded a gross margin of € 159,338 and equity of € 20,460. Compared with financial year 2024, the result moved from € 100,133 to € 111,787. Profitable, and profit is growing. The buffer shrank hard: equity is 96 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 9, 2026.

What it is worth Shrank hard

€ 20,460

▼ 96% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 111,787

▲ 12% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 317,645

▼ 8% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 547,220 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 64,821

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 42,788

▼ 27% vs 2024

€ 16,582 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 70

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 114,637 Gross margin 2022: € 114,637 First fiscal year in the series	€ 173,070 Gross margin 2023: € 173,070 ▲ 51% vs 2022 (€ 114,637) Favourable step	€ 145,898 Gross margin 2024: € 145,898 ▼ 16% vs 2023 (€ 173,070) Unfavourable step	€ 159,338 Gross margin 2025: € 159,338 ▲ 9% vs 2024 (€ 145,898) Favourable step	▲ 9%
Profit after taxes	€ 88,518 Profit after taxes 2022: € 88,518 First fiscal year in the series	€ 126,610 Profit after taxes 2023: € 126,610 ▲ 43% vs 2022 (€ 88,518) Favourable step	€ 100,133 Profit after taxes 2024: € 100,133 ▼ 21% vs 2023 (€ 126,610) Unfavourable step	€ 111,787 Profit after taxes 2025: € 111,787 ▲ 12% vs 2024 (€ 100,133) Favourable step	▲ 12%
Equity	€ 435,032 Equity 2022: € 435,032 First fiscal year in the series	€ 473,407 Equity 2023: € 473,407 ▲ 9% vs 2022 (€ 435,032) Favourable step	€ 455,893 Equity 2024: € 455,893 ▼ 4% vs 2023 (€ 473,407) Unfavourable step	€ 20,460 Equity 2025: € 20,460 ▼ 96% vs 2024 (€ 455,893) Unfavourable step	▼ 96%
Total debts	€ 65 Total debts 2022: € 65 First fiscal year in the series	€ 138,486 Total debts 2023: € 138,486 ▲ € 138,421 vs 2022 (€ 65) Unfavourable step	€ 176,340 Total debts 2024: € 176,340 ▲ 27% vs 2023 (€ 138,486) Unfavourable step	€ 590,078 Total debts 2025: € 590,078 ▲ 235% vs 2024 (€ 176,340) Unfavourable step	▲ 235%
Cash	€ 416,700 Cash 2022: € 416,700 First fiscal year in the series	€ 422,377 Cash 2023: € 422,377 ▲ 1% vs 2022 (€ 416,700) Favourable step	€ 344,852 Cash 2024: € 344,852 ▼ 18% vs 2023 (€ 422,377) Unfavourable step	€ 317,645 Cash 2025: € 317,645 ▼ 8% vs 2024 (€ 344,852) Unfavourable step	▼ 8%
Retained profit	€ 416,432 Retained profit 2022: € 416,432 First fiscal year in the series	€ 454,807 Retained profit 2023: € 454,807 ▲ 9% vs 2022 (€ 416,432) Favourable step	€ 437,293 Retained profit 2024: € 437,293 ▼ 4% vs 2023 (€ 454,807) Unfavourable step	€ 1,860 Retained profit 2025: € 1,860 ▼ € 435,433 vs 2024 (€ 437,293) Unfavourable step	▼ € 435,433
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 88,235 Dividend 2023: € 88,235 Unchanged (€ 0) Unchanged	€ 117,647 Dividend 2024: € 117,647 ▲ 33% vs 2023 (€ 88,235) Unchanged	€ 547,220 Dividend 2025: € 547,220 ▲ € 429,573 vs 2024 (€ 117,647) Unchanged	▲ € 429,573
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 73,939 Bank debt 2023: € 73,939 Unchanged (€ 0) Unfavourable step	€ 58,693 Bank debt 2024: € 58,693 ▼ 21% vs 2023 (€ 73,939) Favourable step	€ 42,788 Bank debt 2025: € 42,788 ▼ 27% vs 2024 (€ 58,693) Favourable step	▼ 27%
Balance sheet total	€ 435,097 Balance sheet total 2022: € 435,097 First fiscal year in the series	€ 611,893 Balance sheet total 2023: € 611,893 ▲ 41% vs 2022 (€ 435,097) Unchanged	€ 632,233 Balance sheet total 2024: € 632,233 ▲ 3% vs 2023 (€ 611,893) Unchanged	€ 610,538 Balance sheet total 2025: € 610,538 ▼ 3% vs 2024 (€ 632,233) Unchanged	▼ 3%

Key figures of DR. LIES CORNELISSEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. LIES CORNELISSEN?

What happened at DR. LIES CORNELISSEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 9, 2026 New annual accounts for financial year 2025: profit of € 111,787 (▲ 12% vs 2024). Source: NBB ↗
Jul 14, 2015 New establishment in Hoogstraten. KBO
Jul 14, 2015 Start of the company according to the CBE. KBO

In short

From € 88,518 profit in 2022 to € 111,787 profit in 2025.

Paid € 114,089 in corporate taxes since 2022.

Best year ever: 2023, with € 126,610 profit.

Paid out € 753,102 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. LIES CORNELISSEN? We notify you, reason included.

Follow DR. LIES CORNELISSEN

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

LIES CORNELISSEN

DR. LIES CORNELISSEN

Behind DR. LIES CORNELISSEN is LIES CORNELISSEN.

See the full network in the app

Directors

According to the 2025 annual accounts

LIES CORNELISSEN

Manager

Establishments

Establishment units

Physical locations of this company

Registered office

Burgemeester J. Van Aperenstraat 44

2320 Hoogstraten

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

All companies at this address →

Dr. Olga Sankina

€ 196,830 gross margin · 2025

IMMO 44

€ 70,379 gross margin · 2025

huisARTSENhuis 44

Huisartsenhuis44 VVZRL

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS huisartsenhuis44.be

Canonical: https://www.huisartsenhuis44.be/

Technologies

ASP.NETAvadaChart.jsContact Form 7LottieNginxPHPWordPressjQuery

Hosting & Email

Email provider

Microsoft 365

Hosting

COMBELL-AS, BE

Domain

huisartsenhuis44.be

Registered

2010-07-05

Website info

HTTPS Ja

Languages NL

Features

Webshop

Security

✓ HTTPS

✓ SPF

✗ DMARC

Details

Company number: 0633.825.714
VAT number: BE 0633.825.714
Registered office: Burgemeester J. Van Aperenstraat 44, 2320 Hoogstraten
Names & denominations: DR. LIES CORNELISSEN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 14 July 2015
Peppol: Active · Active since 14 Jan 2026
Contact: huisartsenhuis44.be

View on CBE Public ↗ Annual accounts (NBB) ↗